Literature DB >> 11030715

Cyclic GMP-independent relaxation of rat pulmonary artery by spermine NONOate, a diazeniumdiolate nitric oxide donor.

K L Homer1, J C Wanstall.   

Abstract

In rat pulmonary artery pre-contracted with phenylephrine, the mechanisms of relaxation to the nitric oxide (NO) donor, spermine NONOate, were investigated. Responses to spermine NONOate were only partially blocked by the soluble guanylate cyclase inhibitor, ODQ (1H:-[1,2,4]Oxadiazolo-[4,3,-a]quinoxalin-1-one) at concentrations up to 30 microM. Ten microM ODQ gave maximal inhibition. Endothelium removal had no effect on the potency of spermine NONOate or its inhibition by ODQ. The protein kinase G inhibitor, Rp-8-Br-cGMPS (100 microM), caused minimal inhibition of spermine NONOate despite causing marked inhibition of glyceryl trinitrate and isosorbide dinitrate. Spermine NONOate (100 microM) caused a 35 fold increase in guanosine 3'5' cyclic monophosphate (cyclic GMP) above basal levels in pulmonary artery rings. ODQ (3 microM) abolished this cyclic GMP production but did not inhibit corresponding relaxant responses. Similar results were seen with another NONOate (MAHMA NONOate; 10 microM). ODQ-resistant relaxation to spermine NONOate (i. e. relaxation seen in the presence of 10 microM ODQ) was inhibited by potassium (80 mM), charybdotoxin (300 nM), iberiotoxin (300 nM), apamin (100 nM), ouabain (1 mM) or thapsigargin (100 nM) but not by 4-aminopyridine (3 mM), glybenclamide (10 microM) or diltiazem (10 microM). Potassium, charybdotoxin, ouabain and thapsigargin also inhibited ODQ-resistant relaxation to FK409 ((+/-)-E:-4-ethyl-2-[E:-hydroxyimino]-5-nitro-3-hexenamide). We conclude that, on rat pulmonary artery, spermine NONOate can produce cyclic GMP-independent relaxation that involves, at least in part, activation of Na(+)/K(+)-ATPase, sarco-endoplasmic reticulum Ca(2+)-ATPase and calcium-activated potassium channels.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11030715      PMCID: PMC1572374          DOI: 10.1038/sj.bjp.0703613

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

Review 1.  The nitric oxide and cGMP signal transduction system: regulation and mechanism of action.

Authors:  H H Schmidt; S M Lohmann; U Walter
Journal:  Biochim Biophys Acta       Date:  1993-08-18

2.  Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase.

Authors:  S L Archer; J M Huang; V Hampl; D P Nelson; P J Shultz; E K Weir
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

3.  Relaxing effect of spermine and spermidine on intact and glycerol-treated muscle.

Authors:  L De Meis
Journal:  Am J Physiol       Date:  1967-01

4.  Novel guanylyl cyclase inhibitor potently inhibits cyclic GMP accumulation in endothelial cells and relaxation of bovine pulmonary artery.

Authors:  F Brunner; K Schmidt; E B Nielsen; B Mayer
Journal:  J Pharmacol Exp Ther       Date:  1996-04       Impact factor: 4.030

5.  "NONOates" (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms.

Authors:  L K Keefer; R W Nims; K M Davies; D A Wink
Journal:  Methods Enzymol       Date:  1996       Impact factor: 1.600

6.  Differential mechanisms of urethral smooth muscle relaxation by several NO donors and nitric oxide.

Authors:  A García-Pascual; G Costa; A Labadía; E Jimenez; D Triguero
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1999-07       Impact factor: 3.000

7.  NO hyperpolarizes pulmonary artery smooth muscle cells and decreases the intracellular Ca2+ concentration by activating voltage-gated K+ channels.

Authors:  X J Yuan; M L Tod; L J Rubin; M P Blaustein
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

8.  cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase.

Authors:  M A Moro; R J Russel; S Cellek; I Lizasoain; Y Su; V M Darley-Usmar; M W Radomski; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

9.  Differential distribution of electrophysiologically distinct myocytes in conduit and resistance arteries determines their response to nitric oxide and hypoxia.

Authors:  S L Archer; J M Huang; H L Reeve; V Hampl; S Tolarová; E Michelakis; E K Weir
Journal:  Circ Res       Date:  1996-03       Impact factor: 17.367

10.  Stimulation of vascular Na(+)-K(+)-ATPase activity by nitric oxide: a cGMP-independent effect.

Authors:  S Gupta; C McArthur; C Grady; N B Ruderman
Journal:  Am J Physiol       Date:  1994-05
View more
  11 in total

1.  Smooth muscle membrane potential modulates endothelium-dependent relaxation of rat basilar artery via myo-endothelial gap junctions.

Authors:  Tracy Allen; Mircea Iftinca; William C Cole; Frances Plane
Journal:  J Physiol       Date:  2002-12-15       Impact factor: 5.182

Review 2.  The biological chemistry of nitric oxide as it pertains to the extrapulmonary effects of inhaled nitric oxide.

Authors:  Andrew J Gow
Journal:  Proc Am Thorac Soc       Date:  2006-04

3.  Gold nanoparticle modifies nitric oxide release and vasodilation in rat aorta.

Authors:  Bruno R Silva; Claure N Lunardi; Koiti Araki; Juliana C Biazzotto; Roberto S Da Silva; Lusiane M Bendhack
Journal:  J Chem Biol       Date:  2014-03-23

4.  Inhibition of rat platelet aggregation by the diazeniumdiolate nitric oxide donor MAHMA NONOate.

Authors:  Kerry L Homer; Janet C Wanstall
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

5.  Sustained release nitric oxide from long-lived circulating nanoparticles.

Authors:  Pedro Cabrales; George Han; Camille Roche; Parimala Nacharaju; Adam J Friedman; Joel M Friedman
Journal:  Free Radic Biol Med       Date:  2010-05-09       Impact factor: 7.376

6.  Vascular smooth muscle relaxation mediated by nitric oxide donors: a comparison with acetylcholine, nitric oxide and nitroxyl ion.

Authors:  J C Wanstall; T K Jeffery; A Gambino; F Lovren; C R Triggle
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

7.  S-nitrosocaptopril: in vitro characterization of pulmonary vascular effects in rats.

Authors:  Debbie Y Y Tsui; Agatha Gambino; Janet C Wanstall
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

8.  ADMA injures the glomerular filtration barrier: role of nitric oxide and superoxide.

Authors:  Mukut Sharma; Zongmin Zhou; Hiroto Miura; Andreas Papapetropoulos; Ellen T McCarthy; Ram Sharma; Virginia J Savin; Elias A Lianos
Journal:  Am J Physiol Renal Physiol       Date:  2009-03-18

9.  P2Y(1) and P2Y(2) receptors are coupled to the NO/cGMP pathway to vasodilate the rat arterial mesenteric bed.

Authors:  Sonja Buvinic; René Briones; J Pablo Huidobro-Toro
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

10.  Nitric oxide suppresses cerebral vasomotion by sGC-independent effects on ryanodine receptors and voltage-gated calcium channels.

Authors:  Kathryn H Yuill; Alister J McNeish; Yasuo Kansui; Christopher J Garland; Kim A Dora
Journal:  J Vasc Res       Date:  2009-09-04       Impact factor: 1.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.